#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14916	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2066	713.8	0	.	n	.	0	C451T	SNP	451	451	C	660	660	T	859	T,C	627,186	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14916	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2066	713.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1393	1393	C	859	C	819	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14916	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2066	713.8	0	HET	.	.	.	C207T	.	207	207	C	416	416	C	839	C,T	579,196	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3540	768.3	0	.	n	.	0	T695C	SNP	695	695	T	1001	1001	C	841	C,T	783,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3540	768.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2277	2277	C	863	C,A	807,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3540	768.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2351	2351	A	848	A	813	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3540	768.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	2903	2903	C	826	C	781	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27344	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3540	768.3	0	HET	.	.	.	A1638G	.	1638	1638	A	1944	1944	A	877	A,G	621,204	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1818	folP	855	855	100.0	folP.l15.c4.ctg.1	1566	115.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1032	1034	AGC	175;177;179	A;G;C	168;165;167	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4944	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	146.6	1	SNP	p	S91F	1	.	.	271	273	TTC	562	564	TTC	167;167;167	T;T;C	153;155;152	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4944	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	146.6	1	SNP	p	G95N	0	.	.	283	285	GGC	574	576	GGC	166;165;166	G;G;C	157;157;158	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4944	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3356	146.6	1	SNP	p	D95G	1	.	.	283	285	GGC	574	576	GGC	166;165;166	G;G;C	157;157;158	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1490	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1402	106.0	1	SNP	p	G45D	0	.	.	133	135	GGC	575	577	GGC	180;181;185	G;G;C	167;170;174	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	752	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	931	80.4	0	.	n	.	0	A197.	DEL	197	197	A	539	539	A	164	A	158	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5694	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2885	196.1	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	231;229;227	G,T;A;C	212,1;205;210	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5694	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2885	196.1	1	SNP	p	S87R	1	.	.	259	261	CGT	586	588	CGT	229;231;231	C;G,A;T	212;209,1;211	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5694	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2885	196.1	1	SNP	p	R87W	0	.	.	259	261	CGT	586	588	CGT	229;231;231	C;G,A;T	212;209,1;211	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5694	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2885	196.1	1	SNP	p	R87I	0	.	.	259	261	CGT	586	588	CGT	229;231;231	C;G,A;T	212;209,1;211	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5694	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2885	196.1	1	SNP	p	S88P	0	.	.	262	264	TCC	589	591	TCC	233;237;240	T;C;C,A	214;218;219,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3958	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2647	148.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1518	1520	GGC	170;167;165	G;G;C	160;157;153	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1202	1204	GCC	196;193;194	G;C;C	186;184;184	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1205	1207	ATG	197;198;199	A;T;G	186;189;190	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1217	1219	ACC	198;200;200	A;C;C	186;191;190	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1217	1219	ACC	198;200;200	A;C;C	186;191;190	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1718	1720	ACC	167;170;175	A;C;C	155;164;166	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1772	1774	GCG	177;174;174	G;C;G	170;168;168	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1772	1774	GCG	177;174;174	G;C;G	170;168;168	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1895	1897	GGT	165;163;162	G;G;T	150;149;148	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1904	1906	AGC	142;141;138	A;G;C	129;129;128	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3870	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2355	163.4	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1922	1924	CCG	123;124;124	C,G;CG,CGG;G	98,3;92,1;100	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5832	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	2834	203.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1475	1477	CCG	195;195;194	C;C;G,C	170;178;171,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2252	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1921	116.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	611	611	C	162	C	145	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2938	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1642	177.6	0	.	p	.	0	G210R	NONSYN	628	630	GGA	894	896	AGA	233;232;233	A;G;A	224;226;223	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2938	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1642	177.6	0	.	p	.	0	S217G	NONSYN	649	651	AGT	915	917	GGT	244;245;247	G,A;G;T	230,1;230;231	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2938	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1642	177.6	1	SNP	p	G120K	1	.	.	358	360	AAG	624	626	AAG	214;212;215	A;A;G	200;199;199	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2938	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1642	177.6	1	SNP	p	N121D	0	.	.	361	363	AAC	627	629	AAC	213;211;213	A;A;C,T	199;199;198,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2938	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1642	177.6	1	SNP	p	A121N	1	.	.	361	363	AAC	627	629	AAC	213;211;213	A;A;C,T	199;199;198,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11284	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4744	236.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1286	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1049	122.1	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	256;258;261	A;T;G	240;241;245	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
